ISSN 1725-2423
Official Journal
of the European Union
C 174
English edition
Information and Notices
Volume 50
27 July 2007
|
ISSN 1725-2423 |
||
|
Official Journal of the European Union |
C 174 |
|
|
|
||
|
English edition |
Information and Notices |
Volume 50 |
|
Notice No |
Contents |
page |
|
|
II Information |
|
|
|
INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES |
|
|
|
Commission |
|
|
2007/C 174/01 |
Non-opposition to a notified concentration (Case COMP/M.4634 — Sabanci/Verbund/Enerjisa JV) ( 1 ) |
|
|
2007/C 174/02 |
Non-opposition to a notified concentration (Case COMP/M.4657 — Salzgitter/KW/RSE) ( 1 ) |
|
|
|
IV Notices |
|
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES |
|
|
|
Commission |
|
|
2007/C 174/03 |
||
|
2007/C 174/04 |
||
|
2007/C 174/05 |
||
|
|
NOTICES FROM MEMBER STATES |
|
|
2007/C 174/06 |
Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 70/2001 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises ( 1 ) |
|
|
2007/C 174/07 |
Amendment by France of public service obligations in respect of scheduled air services between Le Puy-en-Velay and Paris (Orly) ( 1 ) |
|
|
|
V Announcements |
|
|
|
ADMINISTRATIVE PROCEDURES |
|
|
|
European Food Safety Authority |
|
|
2007/C 174/08 |
||
|
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMPETITION POLICY |
|
|
|
Commission |
|
|
2007/C 174/09 |
Prior notification of a concentration (Case COMP/M.4769 — Sumitomo/Itochu/Toyo/AK&N) — Candidate case for simplified procedure ( 1 ) |
|
|
2007/C 174/10 |
Prior notification of a concentration (Case COMP/M.4830 — CVC/Samsonite) — Candidate case for simplified procedure ( 1 ) |
|
|
2007/C 174/11 |
Prior notification of a concentration (Case COMP/M.4744 — INEOS/Borealis) ( 1 ) |
|
|
2007/C 174/12 |
Prior notification of a concentration (Case COMP/M.4734 — INEOS/Kerling) ( 1 ) |
|
|
|
|
|
|
(1) Text with EEA relevance |
|
EN |
|
II Information
INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES
Commission
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/1 |
Non-opposition to a notified concentration
(Case COMP/M.4634 — Sabanci/Verbund/Enerjisa JV)
(Text with EEA relevance)
(2007/C 174/01)
On 30 May 2007, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:
|
— |
from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
|
— |
in electronic form on the EUR-Lex website under document number 32007M4634. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu) |
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/1 |
Non-opposition to a notified concentration
(Case COMP/M.4657 — Salzgitter/KW/RSE)
(Text with EEA relevance)
(2007/C 174/02)
On 25 June 2007, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in German and will be made public after it is cleared of any business secrets it may contain. It will be available:
|
— |
from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
|
— |
in electronic form on the EUR-Lex website under document number 32007M4657. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu) |
IV Notices
NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES
Commission
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/2 |
Euro exchange rates (1)
26 July 2007
(2007/C 174/03)
1 euro=
|
|
Currency |
Exchange rate |
|
USD |
US dollar |
1,3722 |
|
JPY |
Japanese yen |
164,52 |
|
DKK |
Danish krone |
7,4413 |
|
GBP |
Pound sterling |
0,67080 |
|
SEK |
Swedish krona |
9,2266 |
|
CHF |
Swiss franc |
1,6607 |
|
ISK |
Iceland króna |
82,79 |
|
NOK |
Norwegian krone |
7,9760 |
|
BGN |
Bulgarian lev |
1,9558 |
|
CYP |
Cyprus pound |
0,5842 |
|
CZK |
Czech koruna |
28,124 |
|
EEK |
Estonian kroon |
15,6466 |
|
HUF |
Hungarian forint |
249,04 |
|
LTL |
Lithuanian litas |
3,4528 |
|
LVL |
Latvian lats |
0,6969 |
|
MTL |
Maltese lira |
0,4293 |
|
PLN |
Polish zloty |
3,8060 |
|
RON |
Romanian leu |
3,1436 |
|
SKK |
Slovak koruna |
33,353 |
|
TRY |
Turkish lira |
1,7518 |
|
AUD |
Australian dollar |
1,5561 |
|
CAD |
Canadian dollar |
1,4396 |
|
HKD |
Hong Kong dollar |
10,7372 |
|
NZD |
New Zealand dollar |
1,7262 |
|
SGD |
Singapore dollar |
2,0790 |
|
KRW |
South Korean won |
1 260,02 |
|
ZAR |
South African rand |
9,5685 |
|
CNY |
Chinese yuan renminbi |
10,3814 |
|
HRK |
Croatian kuna |
7,2905 |
|
IDR |
Indonesian rupiah |
12 539,16 |
|
MYR |
Malaysian ringgit |
4,7190 |
|
PHP |
Philippine peso |
62,174 |
|
RUB |
Russian rouble |
34,9750 |
|
THB |
Thai baht |
40,651 |
Source: reference exchange rate published by the ECB.
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/3 |
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 June 2007 to 30 June 2007
(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1) )
(2007/C 174/04)
— Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted
|
Date of the decision |
Name of the medicinal product |
INN (International Non-Proprietary Name) |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Pharmaceutical form |
ATC code (Anatomical Therapeutic Chemical Code) |
Date of notification |
||||||
|
1.6.2007 |
Optaflu |
Influenza vaccine (surface antigen, inactivated, prepared in cell culture) |
|
EU/1/07/394/001-006 |
Suspension for injection in pre-filled syringe |
J07BB02 |
5.6.2007 |
||||||
|
14.6.2007 |
Revlimid |
Lenalidomide |
|
EU/1/07/391/001-004 |
Hard capsule |
L04AX04 |
19.6.2007 |
||||||
|
20.6.2007 |
Soliris |
Eculizumab |
|
EU/1/07/393/001 |
Concentrate for solution for infusion |
Non applicable |
22.6.2007 |
||||||
|
25.6.2007 |
Invega |
Paliperidone |
|
EU/1/07/395/001-064 |
Prolonged release tablet |
5N05AX13 |
27.6.2007 |
||||||
|
25.6.2007 |
Pergoveris |
Follitropin alfa/lutropin alfa |
|
EU/1/07/396/001-003 |
Powder and solvent for solution for injection |
G03GA05/G03GA07 |
27.6.2007 |
||||||
|
29.6.2007 |
Circadin |
Melatonin |
|
EU/1/07/392/001 |
Prolonged-release tablet |
N05CM17 |
5.7.2007 |
||||||
|
29.6.2007 |
Siklos |
Hydroxycarbamide |
|
EU/1/07/397/001 |
Film-coated tablet |
L01XX05 |
5.7.2007 |
— Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted
|
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|||||||
|
1.6.2007 |
Renagel |
|
EU/1/99/123/001-012 |
5.6.2007 |
|||||||
|
1.6.2007 |
Rebetol |
|
EU/1/99/107/001-005 |
5.6.2007 |
|||||||
|
4.6.2007 |
Myocet |
|
EU/1/00/141/001 |
7.6.2007 |
|||||||
|
6.6.2007 |
||||||||||
|
4.6.2007 |
Vasovist |
|
EU/1/05/313/001-009 |
6.6.2007 |
|||||||
|
4.6.2007 |
Aptivus |
|
EU/1/05/315/001 |
6.6.2007 |
|||||||
|
4.6.2007 |
Humira |
|
EU/1/03/256/001-010 |
6.6.2007 |
|||||||
|
4.6.2007 |
Trudexa |
|
EU/1/03/257/001-010 |
6.6.2007 |
|||||||
|
4.6.2007 |
Orgalutran |
|
EU/1/00/130/001-002 |
6.6.2007 |
|||||||
|
4.6.2007 |
TRIZIVIR |
|
EU/1/00/156/002-003 |
6.6.2007 |
|||||||
|
4.6.2007 |
Zometa |
|
EU/1/01/176/001-006 |
6.6.2007 |
|||||||
|
4.6.2007 |
Avandamet |
|
EU/1/03/258/001-022 |
6.6.2007 |
|||||||
|
5.6.2007 |
Azomyr |
|
EU/1/00/157/001-067 |
7.6.2007 |
|||||||
|
5.6.2007 |
Aerius |
|
EU/1/00/160/001-069 |
8.6.2007 |
|||||||
|
5.6.2007 |
Neoclarityn |
|
EU/1/00/161/001-067 |
7.6.2007 |
|||||||
|
5.6.2007 |
Abilify |
|
EU/1/04/276/001-020 EU/1/04/276/024-036 |
7.6.2007 |
|||||||
|
5.6.2007 |
Trisenox |
|
EU/1/02/204/001 |
8.6.2007 |
|||||||
|
7.6.2007 |
||||||||||
|
5.6.2007 |
Visudyne |
|
EU/1/00/140/001 |
7.6.2007 |
|||||||
|
7.6.2007 |
Tracleer |
|
EU/1/02/220/001-005 |
11.6.2007 |
|||||||
|
8.6.2007 |
Levemir |
|
EU/1/04/278/001-009 |
12.6.2007 |
|||||||
|
8.6.2007 |
Vistide |
|
EU/1/97/037/001 |
12.6.2007 |
|||||||
|
13.6.2007 |
ViraferonPeg |
|
EU/1/00/132/001-050 |
15.6.2007 |
|||||||
|
13.6.2007 |
Azopt |
|
EU/1/00/129/001-003 |
15.6.2007 |
|||||||
|
13.6.2007 |
Tracleer |
|
EU/1/02/220/001-005 |
15.6.2007 |
|||||||
|
13.6.2007 |
Gardasil |
|
EU/1/06/357/001-017 |
15.6.2007 |
|||||||
|
13.6.2007 |
Ebixa |
|
EU/1/02/219/001-015 |
15.6.2007 |
|||||||
|
13.6.2007 |
PegIntron |
|
EU/1/00/131/001-050 |
15.6.2007 |
|||||||
|
13.6.2007 |
Silgard |
|
EU/1/06/358/001-017 |
15.6.2007 |
|||||||
|
14.6.2007 |
Rapilysin |
|
EU/1/96/018/001 |
19.6.2007 |
|||||||
|
19.6.2007 |
Zyprexa Velotab |
|
EU/1/99/125/001-016 |
21.6.2007 |
|||||||
|
20.6.2007 |
Axura |
|
EU/1/02/218/001-011 |
25.6.2007 |
|||||||
|
20.6.2007 |
Cialis |
|
EU/1/02/237/001-008 |
21.6.2007 |
|||||||
|
21.6.2007 |
Levemir |
|
EU/1/04/278/001-009 |
25.6.2007 |
|||||||
|
21.6.2007 |
PEGASYS |
|
EU/1/02/221/001-010 |
25.6.2007 |
|||||||
|
21.6.2007 |
Hycamtin |
|
EU/1/96/027/001 EU/1/96/027/003-005 |
25.6.2007 |
|||||||
|
21.6.2007 |
Iscover |
|
EU/1/98/070/001a-001b EU/1/98/070/002a-002b EU/1/98/070/003a-003b EU/1/98/070/004a-004b EU/1/98/070/005a-005b EU/1/98/070/006a-006b EU/1/98/070/007a-007b |
25.6.2007 |
|||||||
|
21.6.2007 |
Synagis |
|
EU/1/99/117/001-002 |
25.6.2007 |
|||||||
|
21.6.2007 |
Forsteo |
|
EU/1/03/247/001-002 |
25.6.2007 |
|||||||
|
21.6.2007 |
Revasc |
|
EU/1/97/043/001-003 |
25.6.2007 |
|||||||
|
21.6.2007 |
Cystagon |
|
EU/1/97/039/001-004 |
25.6.2007 |
|||||||
|
21.6.2007 |
PEGASYS |
|
EU/1/02/221/001-010 |
25.6.2007 |
|||||||
|
22.6.2007 |
Plavix |
|
EU/1/98/069/001a-001b EU/1/98/069/002a-002b EU/1/98/069/003a-003b EU/1/98/069/004a-004b EU/1/98/069/005a-005b EU/1/98/069/006a-006b EU/1/98/069/007a-007b |
26.6.2007 |
|||||||
|
25.6.2007 |
M-M-RVAXPRO |
|
EU/1/06/337/001-013 |
27.6.2007 |
|||||||
|
25.6.2007 |
NeoRecormon |
|
EU/1/97/031/001-003 EU/1/97/031/019-046 |
27.6.2007 |
|||||||
|
27.6.2007 |
Vaniqa |
|
EU/1/01/173/001-003 |
29.6.2007 |
|||||||
|
29.6.2007 |
Tamiflu |
|
EU/1/02/222/001-002 |
3.7.2007 |
|||||||
|
29.6.2007 |
Ferriprox |
|
EU/1/99/108/001 |
3.7.2007 |
|||||||
|
3.7.2007 |
||||||||||
|
29.6.2007 |
Humira |
|
EU/1/03/256/001-010 |
5.7.2007 |
|||||||
|
29.6.2007 |
Viramune |
|
EU/1/97/055/001-003 |
5.7.2007 |
|||||||
|
29.6.2007 |
Trudexa |
|
EU/1/03/257/001-010 |
5.7.2007 |
|||||||
|
29.6.2007 |
Prandin |
|
EU/1/00/162/003-006 EU/1/00/162/009-012 EU/1/00/162/015-021 |
5.7.2007 |
|||||||
|
29.6.2007 |
NovoNorm |
|
EU/1/98/076/004-007 EU/1/98/076/011-014 EU/1/98/076/018-024 |
5.7.2007 |
|||||||
|
29.6.2007 |
Tygacil |
|
EU/1/06/336/001 |
5.7.2007 |
|||||||
|
29.6.2007 |
Lyrica |
|
EU/1/04/279/001-035 |
5.7.2007 |
— Issuing of a marketing authorization (Article 38 of Regulation (EC) No 726/2004): Accepted
|
Date of the decision |
Name of the medicinal product |
INN (International Non-Proprietary Name) |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Pharmaceutical form |
ATC code (Anatomical Therapeutic Chemical Code) |
Date of notification |
|||
|
20.6.2007 |
PRILACTONE |
Spironolactone |
|
EU/2/07/074/001-006 |
Tablet |
QC03DA01 |
22.6.2007 |
|||
|
21.6.2007 |
Circovac |
Inactivated porcine circovirus type 2 |
|
EU/2/07/075/001-004 |
Emulsion and suspension for emulsion for injection |
QI09AA07 |
25.6.2007 |
— Modification of a marketing authorization (Article 38 of Regulation (EC) No 726/2004): Accepted
|
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|||
|
14.6.2007 |
Vaxxitek HVT+ IBD |
|
EU/2/02/032/001 |
19.6.2007 |
Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:
|
The European Medicines Agency |
|
7, Westferry Circus |
|
Canary Wharf |
|
London E14 4HB |
|
United Kingdom |
(1) OJ L 136, 30.4.2004, p. 1.
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/10 |
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 June 2007 to 30 June 2007
(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council (1) or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council (2) )
(2007/C 174/05)
— Issuing, maintenance or modification of a national marketing authorisation
|
Date of the decision |
Name(s) of the medicinal product |
Holder(s) of the marketing authorization |
Member State concerned |
Date of notification |
||||||
|
7.6.2007 |
Tracleer |
|
This Decision is addressed to the Member States |
8.6.2007 |
||||||
|
14.6.2007 |
Revlimid |
|
This Decision is addressed to the Member States |
18.6.2007 |
||||||
|
14.6.2007 |
Mifegyne |
See Annex I |
See Annex I |
18.6.2007 |
||||||
|
20.6.2007 |
Soliris |
|
This Decision is addressed to the Member States |
21.6.2007 |
||||||
|
29.6.2007 |
Bovilis BVD |
See Annex II |
See Annex II |
2.7.2007 |
||||||
|
29.6.2007 |
Siklos |
|
This Decision is addressed to the Member States |
3.7.2007 |
— Suspension of a national marketing authorization
|
Date of the decision |
Name(s) of the medicinal product |
Holder(s) of the marketing authorization |
Member State concerned |
Date of notification |
|
13.6.2007 |
Suramox 15 % LA et Stabox 15 % LA |
See Annex III |
See Annex III |
14.6.2007 |
(1) OJ L 311, 28.11.2001, p. 67.
(2) OJ L 311, 28.11.2001, p. 1.
ANNEX I
LIST OF THE INVENTED NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION AND MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
|
Member State |
Marketing Authorisation Holder |
Invented name |
Strength |
Pharmaceutical form |
Route of administration |
||||
|
Austria |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
Belgium |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
Denmark |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
Estonia |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
Finland |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
France |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
Germany |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
Greece |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
Latvia |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
Luxembourg |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
Norway |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
Spain |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
Sweden |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
The Netherlands |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
||||
|
UK |
|
Mifegyne |
200 mg |
Tablet |
Oral use |
ANNEX II
NAME, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ANIMAL SPECIES, ROUTES OF ADMINISTRATION AND MARKETING AUTHORISATION HOLDER
|
Member State |
Applicant or Marketing Authorisation Holder |
Product invented name |
Pharmaceutical form |
Strength |
Animal species |
Frequency and route of administration |
Recommended dose |
||||||||
|
Austria |
|
Bovilis BVD-MD |
Suspension for injection |
Per 2 ml dose: 50 ELISA units, inducing ≥ 4,6 log2 VN units |
Cattle |
Intramuscular injection (Immunisation schedules are given in the product information.) |
One dose = 2 ml |
||||||||
|
Belgium |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Bulgaria |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Cyprus |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Czech Republic |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Denmark |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Estonia |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
France |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Germany |
|
Bovilis BVD-MD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Greece |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Hungary |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Ireland |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Italy |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Latvia |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Lithuania |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Luxembourg |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
The Netherlands |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Poland |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Portugal |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Slovakia |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Slovenia |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
Spain |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
||||||||
|
UK |
|
Bovilis BVD |
As above |
As above |
As above |
As above |
As above |
ANNEX III
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS, ANIMAL SPECIES, FREQUENCY AND ROUTES OF ADMINISTRATION, RECOMMENDED DOSES, WITHDRAWAL PERIODS AND MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES CONCERNED BY THE REFERRAL
|
Member State |
Marketing Authorisation Holder |
Invented name |
Pharmaceutical form |
Strength |
Animal species |
Frequency and route of administration |
Recommended dose |
Withdrawal period (meat and milk) |
||||||||||
|
Czech Republic |
|
Suramox 15 % LA |
Suspension for injection |
150 mg/ml |
Cattle, pigs |
Two intramuscular injections at 48 hours interval |
15 mg amoxicillin/kg bw (equivalent to 1 ml/10 kg) |
Meat and offal:
|
||||||||||
|
Spain (1) |
|
Stabox 15 % LA |
Suspension for injection |
150 mg/ml |
Cattle, pigs |
Two intramuscular injections at 48 hours interval |
15 mg amoxicillin/kg bw (equivalent to 1 ml/10 kg) |
Meat and offal:
|
||||||||||
|
Italy |
|
Stabox 15 % LA |
Suspension for injection |
150 mg/ml |
Cattle, pigs |
Two intramuscular injections at 48 hours interval |
15 mg amoxicillin/kg bw (equivalent to 1 ml/10 kg) |
Meat and offal:
|
||||||||||
|
France (2) |
|
Suramox 15 % LA |
Suspension for injection |
150 mg/ml |
Cattle, pigs |
Two intramuscular injections at 48 hours interval |
15 mg amoxicillin/kg bw (equivalent to 1 ml/10 kg) |
Meat and offal:
|
(1) Marketing Authorisation pending.
(2) Reference Member State for the Mutual recognition Procedure.
NOTICES FROM MEMBER STATES
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/17 |
Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 70/2001 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises
(Text with EEA relevance)
(2007/C 174/06)
|
Aid No |
XS 155/06 |
|||
|
Member State |
Czech Republic |
|||
|
Region |
Czech Republic, except for NUTS II region Prague |
|||
|
Title of aid scheme or name of company receiving individual aid |
Joint regional operational programme Measure 1.1 — Business support in selected regions Sub-measure 4.2.2. — Support for regional and local tourism infrastructure |
|||
|
Legal basis |
Usnesení vlády č. 102 ze dne 23. ledna 2002 Usnesení vlády č. 149 ze dne 12. února 2003 Usnesení vlády č. 79/2003 Zákon č. 248/2000 Sb., o podpoře regionálního rozvoje, v platném znění Zákon č. 215/2004 Sb., o úpravě některých vztahů v oblasti veřejné podpory a o změně zákona o podpoře výzkumu a vývoje, v platném znění Nařízení Komise (ES) č. 70/2001 |
|||
|
Annual expenditure planned or overall amount of individual aid granted to the company |
Aid scheme |
Annual overall amount |
EUR 58,182 million (1) |
|
|
Loans guaranteed |
— |
|||
|
Individual aid |
Overall aid amount |
— |
||
|
Loans guaranteed |
— |
|||
|
Maximum aid intensity |
In conformity with Articles 4(2)-(6) and 5 of the Regulation |
Yes |
||
|
Date of implementation |
1.1.2007 |
|||
|
Duration of scheme or individual aid award |
Until 31.12.2007 |
|||
|
Objective of aid |
Aid to SMEs |
Yes |
||
|
Economic sectors concerned |
All sectors eligible for aid to SMEs |
Yes |
||
|
Name and address of the granting authority |
Ministerstvo pro místní rozvoj |
|||
|
||||
|
Large individual aid grants |
In conformity with Article 6 of the Regulation |
No None to be granted |
||
|
Aid No |
XS 172/06 |
|||
|
Member State |
Germany |
|||
|
Region |
Berlin |
|||
|
Title of aid scheme or name of company receiving individual aid |
Sulfurcell Solartechnik GmbH |
|||
|
Legal basis |
Gesetz über die Gemeinschaftsaufgabe „Verbesserung der regionalen Wirtschaftsstruktur“ vom 6.10.1969 (BGBl. I, S. 1861), zuletzt geändert durch Art. 102 der Achten Zuständigkeitsanpassungsverordnung vom 25.11.2003 (BGBl. I, S. 2304 ff) 35. Rahmenplan der Gemeinschaftsaufgabe „Verbesserung der regionalen Wirtschaftsstruktur“ (GA) für den Zeitraum 2006 bis 2009, veröffentlicht im Bundesanzeiger Nr. 240 am 20.12.2005 |
|||
|
Annual expenditure planned or overall amount of individual aid granted to the company |
Aid scheme |
Annual overall amount |
— |
|
|
Loans guaranteed |
— |
|||
|
Individual aid |
Overall aid amount: (Joint scheme funds: EUR 5 204 100) (Investment grants (2): EUR 16 412 660) |
EUR 21 616 760 |
||
|
Loans guaranteed |
— |
|||
|
Maximum aid intensity |
In conformity with Articles 4(2)-(6) and 5 of the Regulation |
Yes |
||
|
Date of implementation |
28.8.2006 (3) |
|||
|
Duration of scheme or individual aid award |
Until 31.12.2009 (4) |
|||
|
Objective of aid |
Aid to SMEs |
Yes |
||
|
Economic sectors concerned |
Limited to specific sectors |
Yes |
||
|
Other manufacturing |
Yes |
|||
|
Name and address of the granting authority |
Investitionsbank Berlin |
|||
|
||||
|
Large individual aid grants |
In conformity with Article 6 of the Regulation |
Yes |
||
|
Aid No |
XS 173/06 |
|||||
|
Member State |
Finland |
|||||
|
Region |
Aid area I in the development area designated by government decision on the basis of the Regional Development Act No 602/2002 |
|||||
|
Title of aid scheme or name of company receiving individual aid |
Accelerated depreciation for investments made by SMEs in the development area |
|||||
|
Legal basis |
Kehitysalueelle tehtävien investointien korotetuista poistoista annettu laki (1262/1993, muut. 1736/1995, 32/1998, 1215/1998, 964/2000, 901/2001, 914/2003 et 979/2006). |
|||||
|
Annual expenditure planned under the scheme or overall amount of individual aid granted to the company |
Aid scheme |
Annual overall amount |
Approx. EUR 1 million (5) |
|||
|
Loans guaranteed |
|
|||||
|
Individual aid |
Overall aid amount |
|
||||
|
Loans guaranteed |
|
|||||
|
Maximum aid intensity |
In conformity with Articles 4(2)-(6) and 5 of the Regulation |
Yes Maximum aid intensity: 1 % |
||||
|
Date of implementation |
From 1.1.2007 |
|||||
|
Duration of scheme or individual aid award |
Until 31.12.2008 |
|||||
|
Objective of aid |
Aid to SMEs |
Yes |
||||
|
Economic sectors concerned |
All sectors eligible for aid to SMEs |
Yes |
||||
|
Limited to specific sectors |
Yes |
|||||
|
No |
|||||
|
|
|||||
|
or |
|
|||||
|
Steel |
No |
|||||
|
Shipbuilding |
No |
|||||
|
Synthetic fibres |
No |
|||||
|
Motor vehicles |
No |
|||||
|
Other manufacturing |
Yes |
|||||
|
|
|||||
|
or |
|
|||||
|
Transport services |
No |
|||||
|
Financial services |
No |
|||||
|
Tourism |
Yes |
|||||
|
Other services |
No |
|||||
|
Name and address of the granting authority |
|
|||||
|
Large individual aid grants |
In conformity with Article 6 of the Regulation |
Yes |
||||
|
Aid No |
XS 175/06 |
|||||
|
Member State |
Italy |
|||||
|
Region |
Campania |
|||||
|
Title of aid scheme or name of company receiving individual aid |
Aid scheme for SMEs to build plant for the recovery of materials from waste from specific production categories, to build energy recycling plant for waste not otherwise recoverable and to adapt the technology of existing waste recovery plant (processing of inert waste, motor vehicles, durables, bulky items, quality composting, recovery of plastics) |
|||||
|
Legal basis |
POR Campania 2000-2006 Complemento di programmazione, misura 1.7, azioni e) e g) DGR n. 317 del 4.3.2005 di approvazione dei criteri ed indirizzi, modificata con DGR n. 1545 del 5.10.2006 e DGR n. 1633 del 17.10.2006 Decreto dirigenziale n. 955 del 14.11.2006 pubblicato sul B.U.R.C. del 20.11.2006 |
|||||
|
Annual expenditure planned under the scheme |
Aid scheme |
Annual overall amount |
EUR 35,5 million |
|||
|
Loans guaranteed |
No |
|||||
|
Maximum aid intensity |
In conformity with Articles 4(2)-(6) and 5 of the Regulation |
Yes The maximum aid intensity is 35 % nge, plus 15 % gge calculated on the basis of eligible costs relating to land, buildings, construction and related activities, plant, machinery, brand new equipment and intangible assets and 50 % gge of eligible costs relating to planning and studies and support services |
||||
|
Date of implementation |
From 21.12.2006 |
|||||
|
Duration of scheme |
Until 31.12.2006 |
|||||
|
Objective of aid |
Aid to SMEs |
Yes |
||||
|
Economic sectors concerned |
Limited to specific sectors |
Yes |
||||
|
Other services |
Yes — Waste management |
|||||
|
Name and address of the granting authority |
Regione Campania Area Generale di Coordinamento 05 Settore 02 Responsabile della Misura 1.7 del POR Campania 2000-2006 |
|||||
|
||||||
|
Large individual aid grants |
In conformity with Article 6 of the Regulation |
Yes |
||||
|
Aid No |
XS 182/06 |
|||||||
|
Member State |
(United Kingdom and) Republic of Ireland |
|||||||
|
Region |
32 Counties of the island of Ireland — Northern Ireland and Republic of Ireland |
|||||||
|
Title of aid scheme or name of company receiving an individual aid |
Consultancy Aid for Software Development |
|||||||
|
Legal Basis |
British/Irish Agreement Act 1999 Section 2.3 Part 7 of Annex 2 of the act empowers Inter Trade Ireland to invest, lend or grant aid for the purposes of its function |
|||||||
|
Annual expenditure planned under the scheme or overall amount of individual aid granted to the company |
Total Cost of Scheme: 2006: GBP 70 000 2007: GBP 86 000 The scheme will be implemented on a rolling basis during 2006-2007. Cost of the project is GBP 156 000 over 12 months duration Total funding element for the scheme = GBP 6 000. This represents 37 % of the total project cost with the remaining 63 % attributed by the participating enterprise |
|||||||
|
Maximum aid intensity |
Up to a maximum of 37 % aid intensity |
|||||||
|
Date of implementation |
Proposed scheme to run for 1 year from date of approval Individual companies will be eligible for assistance for a maximum of 12 months |
|||||||
|
Duration of scheme or individual aid award |
Scheme will run until the end of 2007 |
|||||||
|
Objective of aid |
To provide consultancy aid to SMEs in the software sector towards the cost of technology development and promotion of an integrated solution for mobile technology products |
|||||||
|
Economic Sector(s) concerned |
Other services |
|||||||
|
Name and address of the granting authority |
|
|
Aid No |
XS 183/06 |
||||
|
Member State |
Netherlands |
||||
|
Region |
Provincie Fryslân |
||||
|
Title of aid scheme or name of company receiving individual aid |
Van der Velden Systeemtechniek B.V. in Drachten |
||||
|
Legal basis |
Algemene wet bestuursrecht 4.2 Algemene subsidieverordening SNN |
||||
|
Annual expenditure planned under the scheme or overall amount of individual aid granted to the company |
Aid scheme |
Annual overall amount |
— |
||
|
Loans guaranteed |
— |
||||
|
Individual aid |
Overall aid amount |
EUR 194 640 |
|||
|
Loans guaranteed |
— |
||||
|
Maximum aid intensity |
In conformity with Articles 4(2)-(6) and 5 of the Regulation The total project costs are EUR 486 600. The total eligible costs are EUR 486 600. The aid to be provided by SNN totals EUR 194 640 (aid intensity of 35 % under Article 5a(3)(c), increased by 5 % under Article 5a(4)(a) inserted by Commission Regulation (EC) No 364/2004 amending Regulation (EC) No 70/2001 as regards the extension of its scope to include aid for research and development making a total of 40 %) |
Yes |
|||
|
Date of implementation |
22.12.2006 |
||||
|
Duration of scheme or individual aid award |
Until 1.9.2009 |
||||
|
Objective of aid |
Aid to SMEs The objective of the project is to develop a shaftless propulsion system |
Yes |
|||
|
Economic sectors concerned |
Limited to specific sectors |
Yes |
|||
|
Other manufacturing |
Yes, systems technology |
||||
|
Name and address of the granting authority |
Samenwerkingsverband Noord-Nederland |
||||
|
|||||
|
Large individual aid grants |
In conformity with Article 6 of the Regulation |
Yes |
|||
|
Aid No |
XS 184/06 |
||||
|
Member State |
Netherlands |
||||
|
Region |
Provincie Fryslân |
||||
|
Title of aid scheme or name of company receiving individual aid |
JB Besturingstechniek B.V. in Oosterwolde |
||||
|
Legal basis |
Algemene wet bestuursrecht 4.2 Algemene subsidieverordening SNN |
||||
|
Annual expenditure planned under the scheme or overall amount of individual aid granted to the company |
Aid scheme |
Annual overall amount |
— |
||
|
Loans guaranteed |
— |
||||
|
Individual aid |
Overall aid amount |
EUR 80 740 |
|||
|
Loans guaranteed |
— |
||||
|
Maximum aid intensity |
In conformity with Articles 4(2)-(6) and 5 of the Regulation The total project costs are EUR 201 850. The total eligible costs are EUR 201 850. The aid to be provided by SNN totals EUR 80 740 (aid intensity of 35 % under Article 5a(3)(c) increased by 5 % under Article 5a(4)(a) inserted by Commission Regulation (EC) No 364/2004 amending Regulation (EC) No 70/2001 as regards the extension of its scope to include aid for research and development making a total of 40 %) |
Yes |
|||
|
Date of implementation |
22.12.2006 |
||||
|
Duration of scheme or individual aid award |
Until 1.9.2009 |
||||
|
Objective of aid |
Aid to SMEs The objective of the project is to develop a shaftless propulsion system |
Yes |
|||
|
Economic sectors concerned |
Limited to specific sectors |
Yes |
|||
|
Other manufacturing |
Yes, control technology |
||||
|
Name and address of the granting authority |
Samenwerkingsverband Noord-Nederland |
||||
|
|||||
|
Large individual aid grants |
In conformity with Article 6 of the Regulation |
Yes |
|||
|
Aid No |
XS 185/06 |
||||
|
Member State |
Netherlands |
||||
|
Region |
Provincie Drenthe |
||||
|
Title of aid scheme or name of company receiving individual aid |
Combimac B.V. in Emmen |
||||
|
Legal basis |
Algemene wet bestuursrecht 4.2 Algemene subsidieverordening SNN |
||||
|
Annual expenditure planned under the scheme or overall amount of individual aid granted to the company |
Aid scheme |
Annual overall amount |
— |
||
|
Loans guaranteed |
— |
||||
|
Individual aid |
Overall aid amount |
EUR 132 660 |
|||
|
Loans guaranteed |
— |
||||
|
Maximum aid intensity |
In conformity with Articles 4(2)-(6) and 5 of the Regulation The total project costs are EUR 331 650. The total eligible costs are EUR 331 650. The aid to be provided by SNN totals EUR 132 660 (aid intensity of 35 % under Article 5a(3)(c), increased by 5 % under Article 5a(4)(a), inserted by Commission Regulation (EC) No 364/2004 amending Regulation (EC) No 70/2001 as regards the extension of its scope to include aid for research and development, making a total of 40 %) |
Yes |
|||
|
Date of implementation |
22.12.2006 |
||||
|
Duration of scheme or individual aid award |
Until 1.9.2009 |
||||
|
Objective of aid |
Aid to SMEs The objective of the project is to develop a shaftless propulsion system |
Yes |
|||
|
Economic sectors concerned |
Limited to specific sectors |
Yes |
|||
|
Other manufacturing |
Yes, electric motors |
||||
|
Name and address of the granting authority |
Samenwerkingsverband Noord-Nederland |
||||
|
|||||
|
Large individual aid grants |
In conformity with Article 6 of the Regulation |
Yes |
|||
|
Aid No |
XS 186/06 |
|||||||||||||||||
|
Member State |
Ireland |
|||||||||||||||||
|
Region |
All regions |
|||||||||||||||||
|
Title of aid scheme or name of company receiving individual aid |
SME Development Scheme |
|||||||||||||||||
|
Legal basis |
The Industrial Development Act 1986 as amended Údarás na Gaeltachta Act 1979 as amended. Shannon Free Airport Development Company Limited Act 1959, as amended. |
|||||||||||||||||
|
Annual expenditure planned under the scheme or overall amount of individual aid granted to the company |
Aid scheme |
Estimated annual overall amount |
EUR 40 million |
|||||||||||||||
|
Individual aid |
Overall aid amount |
— |
||||||||||||||||
|
Loans guaranteed |
— |
|||||||||||||||||
|
Maximum aid intensity |
In conformity with Articles 4(2)-(6) and 5 of the Regulation |
Yes |
||||||||||||||||
|
Date of implementation |
1.1.2007 |
|||||||||||||||||
|
Duration of scheme or individual aid award |
2007-2013 subject to revision of SME Regulation (EC) No 70/2001 |
|||||||||||||||||
|
Objective of aid |
Aid to SMEs |
Yes |
||||||||||||||||
|
Economic sectors concerned |
Limited to specific sectors |
Yes |
||||||||||||||||
|
No |
|||||||||||||||||
|
No |
|||||||||||||||||
|
or |
|
|||||||||||||||||
|
Steel |
No |
|||||||||||||||||
|
Shipbuilding |
No |
|||||||||||||||||
|
Synthetic fibres |
No |
|||||||||||||||||
|
Motor vehicles |
Yes |
|||||||||||||||||
|
Other manufacturing |
Yes |
|||||||||||||||||
|
Yes |
|||||||||||||||||
|
or |
|
|||||||||||||||||
|
Transport services |
Yes |
|||||||||||||||||
|
Financial services |
Yes |
|||||||||||||||||
|
Other services |
Yes |
|||||||||||||||||
|
Name and address of the granting authority |
|
|||||||||||||||||
|
Large individual aid grants |
Large individual aid grants as defined in Article 6 of Regulation (EC) No 70/2001 are not exempted from prior notification to the Commission |
|||||||||||||||||
|
Aid No |
XS 188/06 |
|||
|
Member State |
Finland |
|||
|
Region |
Whole country |
|||
|
Title of aid scheme or name of company receiving individual aid |
Guarantee commission aid for SMEs (Takausprovisiotuki pk-yrityksille) |
|||
|
Legal basis |
Valtion erityisrahoitusyhtiöstä annettu laki (443/1998), valtion erityisrahoitusyhtiön luotto- ja takaustoiminnasta annettu laki (445/1998), Valtioneuvoston sitoumus Finnvera Oyj:lle takausprovisiotuen maksamisesta (1/023/2005) |
|||
|
Annual expenditure planned under the scheme or overall amount of individual aid granted to the company |
Aid scheme |
Annual overall amount |
Approx. EUR 1,7 million |
|
|
Loans guaranteed |
EUR 26 millions |
|||
|
Individual aid |
Overall aid amount |
— |
||
|
Loans guaranteed |
— |
|||
|
Maximum aid intensity |
In conformity with Articles 4(2)-(6) and 5 of the Regulation |
Yes |
||
|
Date of implementation |
1.1.2007 |
|||
|
Duration of scheme or individual aid award |
Until 31.12.2007 |
|||
|
Objective of aid |
Aid to SMEs |
Yes |
||
|
Sector(s) concerned |
All sectors eligible for aid to SMEs |
Yes |
||
|
Name and address of the granting authority |
Finnvera Oyj Kotimaan alueellinen rahoitus |
|||
|
||||
|
Large individual aid grants |
In conformity with Article 6 of the Regulation |
|||
|
Aid No |
XS 21/07 |
||||||||||||||||||||
|
Member State |
Italy |
||||||||||||||||||||
|
Region |
Sicilia and Valle d'Aosta |
||||||||||||||||||||
|
Title of aid scheme or name of company receiving individual aid |
Financial aid for the purchase or lease of new production machines and tools |
||||||||||||||||||||
|
Legal basis |
Legge 28.11.1965, n. 1329 Deliberazione del Comitato Agevolazioni Nazionale del 21.12.2006 |
||||||||||||||||||||
|
Annual expenditure planned or overall amount of individual aid granted to the company |
Aid scheme |
Annual overall amount |
EUR 10 million |
||||||||||||||||||
|
Loans guaranteed |
— |
||||||||||||||||||||
|
Individual aid |
Overall aid amount |
— |
|||||||||||||||||||
|
Loans guaranteed |
— |
||||||||||||||||||||
|
Maximum aid intensity |
The scheme is subject to the aid ceilings laid down by Article 4 of the Regulation The contribution is calculated on the basis of the amount eligible for aid and is equal to be the difference between:
in force on the date on which the loan is granted The interest rate for recipient companies is:
Enterprises from either Sicily or Valle d'Aosta investing in the production and marketing of agricultural products sector may not benefit from an aid intensity higher than:
|
||||||||||||||||||||
|
Date of implementation |
1.1.2007 |
||||||||||||||||||||
|
Duration of scheme or individual aid award |
Until the expiry date of Regulation (EC) No 70/2001 set by Article 10 of the same Regulation and subsequent amendments and additions |
||||||||||||||||||||
|
Objective of aid |
Aid to SMEs |
Yes |
|||||||||||||||||||
|
Economic sectors concerned |
The aid is intended for SMEs, with the following exceptions:
The aid is also subject to specific restrictions for the following sectors:
|
||||||||||||||||||||
|
Name and address of the granting authority |
|
||||||||||||||||||||
(1) The amount relates to 2007 and is made up as follows:
Structural funds: EUR 42,248 million; national public sources: EUR 15,934 million (exchange rate: CZK/EUR 28,465).
(2) The investments concerned must be made in the period between December 2006 and November 2009. For investments scheduled for before 1 January 2007, the investment grant rates under the Investment Grant Act 2005 were taken into account. For investments from 2007 to 2009, the grant rates under the Investment Grant Act 2007 were used.
(3) The award decision for the grant from joint scheme funds was issued on 28 August 2006, with a stipulation (ancillary clause to the administrative decision pursuant to Article 36 of the Administrative Procedure Act) that the grant could be paid only after the planned aid was notified under EU rules. On this basis, the actual date of implementation will be the date of approval by the EU.
(4) The investments must be made in the period between December 2006 and November 2009. The aid is to be paid out in annual instalments in accordance with the progress of the investment project.
(5) The advantage the companies get from the tax relief comprises the interest benefit from the frontloading of the depreciation, amounting to EUR 0,5 million on the investments over a year.
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/27 |
Amendment by France of public service obligations in respect of scheduled air services between Le Puy-en-Velay and Paris (Orly)
(Text with EEA relevance)
(2007/C 174/07)
|
1. |
France has decided to alter, with effect from 14 January 2008, the public service obligation pursuant to Article 4(1)(a) of Council Regulation (EEC) No 2408/92 of 23 July 1992 on access for Community air carriers to intra-Community air routes, in respect of scheduled air services between the airports of Le Puy-en-Velay (Loudes) and Paris (Orly) (1). These obligations replace those published in Official Journal of the European Communities C 227 of 1.9.1995 and amended in Official Journal of the European Communities C 258 of 15.9.2001. |
|
2. |
The new public service obligation is as follows: Minimum frequency The minimum level of service provided must be two return trips a day, morning and evening, from Monday to Friday, excluding public holidays, 220 days a year. The service must be non-stop between Le Puy-en-Velay (Loudes) and Paris (Orly). Type of aircraft used The service must be operated with a pressurised aircraft having a seating capacity of at least 19. Timetables During the week, the timetables must allow passengers to make a round trip within the day and to spend at least seven hours and thirty minutes in Le Puy-en-Velay and eight hours in Paris. Fares The maximum cost of a one-way ticket is EUR 223 (as at January 2008). This fare excludes per capita taxes and duties other than the value added tax levied by the State, local authorities and airport authorities, and identified as such on the air ticket. It will be revised each year on the basis of the index of the cost of transport services published by the National Institute for statistics and economic studies (Institut national de la statistique et des études économiques). If an abnormal and unforeseeable increase in the cost factors affecting the operation of the routes takes place for which the carriers are not responsible, this maximum fare may be raised in proportion to the increase. It will be notified to the carriers operating the services and will apply within an appropriate period after being communicated to the European Commission for publication in the Official Journal of the European Union. Continuity of service Except in cases of force majeure, the number of flights cancelled for reasons directly attributable to the carrier must not exceed 3 % of the number of flights scheduled in any year. The carrier must give six months' notice before discontinuing the services. Community carriers are hereby informed that the operation of air services without regard to the abovementioned public service obligations may result in administrative and/or criminal penalties. |
|
3. |
Slots are currently reserved at Paris (Orly) airport for the scheduled Paris (Orly) — Le Puy-en-Velay service pursuant to Article 9 of Council Regulation (EEC) No 95/93 of 18 January 1993 on common rules for the allocation of slots at Community airports (2). Carriers interested in this route can obtain information on the slots from the Paris airports coordinator. |
(1) OJ L 240, 24.9.1992, p. 8.
(2) OJ L 14, 22.1.1993, p. 1. Regulation as last amended by Regulation (EC) No 793/2004 of the European Parliament and of the Council (OJ L 138, 30.4.2004, p. 50).
V Announcements
ADMINISTRATIVE PROCEDURES
European Food Safety Authority
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/28 |
Call for expressions of interest for the position of member of the Management Board of the European Food Safety Authority
(2007/C 174/08)
Applications are invited for the positions of 7 out of 14 members of the Management Board of the European Food Safety Authority established by Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety (1). The Authority is located in Parma, Italy.
The European Food Safety Authority
The European Food Safety Authority (EFSA) is the keystone of European Union risk assessment regarding food and feed safety. The Authority was established to provide scientific advice and support for Community legislation and policies in all fields that may have a direct or indirect impact on food and feed safety, as well as closely associated questions in the field of animal health and welfare and plant health. It provides independent information on these matters and communicates on risks. Its mission also includes provision of scientific advice on nutrition, particularly in relation to Community legislation, and GMOs, including also new food technologies. The Authority has rapidly earned a reputation with its stakeholders as the accepted point of reference by virtue of its independence, the scientific quality of its opinions and public information, the transparency of its procedures and its diligence in performing its tasks. In addition to having its own specialist personnel, the Authority is supported by networks of competent organisations in the EU.
Legal background
In accordance with Art. 25 of the above-mentioned Regulation, ‘the members of the Board shall be appointed in such a way as to secure the highest standards of competence, a broad range of relevant expertise and, consistent with these, the broadest possible geographic distribution within the Union’. In addition, four of the members of the Management Board ‘shall have their background in organisations representing consumers and other interests in the food chain’.
Furthermore, Recital 40 of the aforementioned Regulation stipulates that ‘Cooperation with Member States is also indispensable’ and Recital 41 states that ‘the Management Board should be appointed in such a way as to secure the highest standard of competence, a broad range of relevant expertise, for instance in management and in public administration, and the broadest possible geographic distribution within the Union. This should be facilitated by a rotation of the different countries of origin of the members of the Management Board without any post being reserved for nationals of any specific Member State.’
Role and operation of the Management Board
The responsibilities of the Management Board include, in particular:
|
— |
general monitoring of the work of the Authority to ensure that it carries out its mission and performs the tasks assigned to it in accordance with its mandate and within a culture of independence and transparency, |
|
— |
the appointment of the Executive Director on the basis of the list drawn up by the Commission, and, if necessary, his or her dismissal, |
|
— |
the appointment of the members of the Scientific Committee and Panels which are responsible for providing the scientific opinions of the Authority, |
|
— |
the adoption of annual and multi-annual programmes of work of the Authority and the general report of annual activities, |
|
— |
the adoption of the Authority's internal rules and financial regulation. |
The Board operates by formal meetings, private sessions, informal contacts between members and correspondence. EFSA papers, Board correspondence and private or informal sessions are held in English. Formal sessions include interpretation where Members need this. The Board meets four to six times per year, predominantly in Parma but also in other EU locations where appropriate.
Composition of the Management Board
The Management Board is composed of 14 members appointed by the Council in consultation with the European Parliament, plus a representative of the Commission. The 14 members of the Management Board have been appointed on 15 July 2002 by Council Decision (2), the term of office for 7 of whom expired on 30 June 2006. They were replaced or had their mandate renewed until 30 June 2010 by Council Decision 2006/478/EC (3). The term of office of the other seven members of the Management Board will end on 30 June 2008. Three of them were appointed as having a background in organisations representing consumers and other interests in the food chain.
Current membership of the Board can be seen on EFSA's website:
http://www.efsa.europa.eu/en/mboard/members.html
This publication concerns applications for the positions of those seven members of the first Management Board whose term expires on 30 June 2008.
Qualifications for the position
The members of the Management Board need the competence and collective expertise necessary to guide the Authority on matters relating to its mission, particularly to ensure:
|
1. |
efficient delivery of scientific advice and support to meet the European Community's needs in relation to its legislation and policies and its work in the public interest; |
|
2. |
application of sound principles of management and public administration; |
|
3. |
its functioning is guided by the principles of integrity, independence, transparency, ethical practices and high scientific quality while maintaining the indispensable cooperation with Member States; |
|
4. |
communication and information to the public on scientific issues; |
|
5. |
the creation and maintenance of a reputation for a high level of excellence, objectivity and reliability with its stakeholders; |
|
6. |
promotion of the necessary coherence between risk assessment, risk management and risk communication functions. |
Candidates will need to demonstrate that they can contribute effectively to one or more of the areas listed above. They must have had at least 15 years of experience in one or more of these areas, including at least 5 years at a senior level. Candidates shall have at least five years of experience gained from work in connection with food and feed safety or other areas related to the Authority's mission, notably in the field of animal health and welfare, protection of the environment (4), plant health and nutrition. On the basis of their experience, candidates shall demonstrate their ability to operate in a multilingual, multicultural and multidisciplinary environment. Candidates will be selected on the basis of comparative merits in relation to the above-mentioned criteria and, consistent with these, of the broadest possible geographic distribution within the Union.
Independence and declarations of commitment and interest
Board members will be nominated in a personal capacity. They will be required to make a declaration of commitment to act independently in the public interest and to make a declaration in relation to interests which might be considered prejudicial to their independence. Therefore, in line with the principle of independence in the functioning of the Board, applicants are asked to indicate in the application form any direct or indirect relationship they consider to be relevant to the mission of the Authority.
Participation in the Board meetings
Members will need to make a high level of commitment to participate in the meetings of the Management Board. They are asked to indicate in the application form their availability to actively participate in the Management Board. It is estimated that the Management Board will meet four to six times per year. Members of the Board are not remunerated, but will be reimbursed for their normal travel and subsistence costs. They will also receive indemnities for each day spent at meetings in accordance with Art. 15 of the Rules of Procedure of the Management Board of EFSA, which states that ‘members of the Management Board other than the Commission representative and those employed by a national public body or institution will receive a daily indemnity of EUR 300 for each meeting of the Board for which he/she is present’.
Members of the Management Board having a background in organisations representing consumers and other interests in the food chain
Candidates are asked to indicate if their application could be considered as an expression of interest in the context of such Board Members and, if so, to provide details of their background in organisations representing consumers and other interests in the food chain.
Appointment and term of mandate
With the exception of the Commission representative, who is appointed by the Commission, members of the Management Board are appointed by the Council, in consultation with the European Parliament, from the list drawn up by the Commission on the basis of this call for expressions of interest. The term of office shall be four years and can be renewed once. Applicants should note that the Commission's list will be made public. Individuals on the Commission's list who are not appointed may be invited to constitute a reserve list to be used in the event of the need to replace members who are unable to complete their mandate.
Nationality
In this call, the Commission will seek to establish a short-list that, consistent with appointments securing the highest standards of competence and a broad range of expertise, will enable the appointments also to meet the objective of ‘the broadest possible geographical distribution’ to be facilitated by ‘a rotation of the different countries of origin of the Members’. It should be noted that the members whose terms of office ends on 30 June 2010 already include nationals of Belgium, Denmark, France, Greece, Hungary, Netherlands, Sweden, and that outgoing members (who may re-apply) include nationals of Finland, Germany, Ireland, Italy, Portugal, Slovenia and United Kingdom. To date, the Board has not included nationals of Bulgaria, Cyprus, Czech Republic, Estonia, Latvia, Lithuania, Luxembourg, Malta, Poland, Romania, and Slovakia. This Call is open to nationals of any EU Member State. Applicants must be nationals of an EU Member State.
Equal Opportunities
The European Union takes great care to avoid any form of discrimination and actively encourages applications from women.
APPLICATION PROCEDURE AND CLOSING DATE
Applications shall comply with the requirements set out below; otherwise they will not be taken into consideration:
|
1. |
Interested persons must use the attached form, which can also be downloaded from the Health and Consumer Protection Directorate-General's website at: http://ec.europa.eu/food/efsa/efsa_management_board_en.htm |
|
2. |
The application must be complete. It must include the application, as referred to in paragraph 3 below in one original printed version and three copies. |
|
3. |
The application must include:
|
|
4. |
The letter of motivation, the application form, the CV, and the supporting documents have to be written in an official language of the European Community. It would, however, be desirable to include a summary of experience and other pertinent information in English in order to facilitate the selection procedure. All applications will be treated as confidential. Supporting documents must be submitted at a later stage, if requested. |
|
5. |
The final deadline for submission of applications is 24.9.2007. |
|
6. |
The complete application must be sent:
not later than 16.00 on 24.9.2007. In this case, a receipt must be obtained as proof of submission, signed and dated by the official in the Commission's central mail department who took delivery. The department is open from 8.00 to 17.00 Monday to Thursday, and from 8.00 to 16.00 on Fridays. It is closed on Saturdays, Sundays and Commission holidays. Neither the applications sent by electronic mail or fax, nor those sent directly to the European Food Safety Authority will be accepted. |
|
7. |
In submitting an application, applicants accept the procedures and conditions as described in this call and in the documents to which it refers. In compiling their application, applicants may under no circumstances refer to any documents of any type submitted in prior applications (example: photocopies of previous applications will not be accepted). Any misrepresentation in supplying the required information may lead to the exclusion from the present Call. |
(2) OJ C 179, 27.7.2002, p. 9.
(3) OJ L 189, 12.7.2006, p. 7.
(4) Ecology, protection of the biodiversity.
PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMPETITION POLICY
Commission
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/37 |
Prior notification of a concentration
(Case COMP/M.4769 — Sumitomo/Itochu/Toyo/AK&N)
Candidate case for simplified procedure
(Text with EEA relevance)
(2007/C 174/09)
|
1. |
On 18 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1), by which Sumitomo Chemical Company (‘Sumitomo’, Japan), Itochu Corporation (‘Itochu’, Japan) and Toyo Ink Mfg. (‘Toyo’, Japan) acquire, within the meaning of Article 3(1)(b) of the Council Regulation, joint control of AK&N UK Ltd (‘AK&N’, UK) by way of purchase of shares. |
|
2. |
The business activities of the undertakings concerned are:
|
|
3. |
On preliminary examination, the Commission finds that the notified concentration could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
|
4. |
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4769 — Sumitomo/Itochu/Toyo/AK&N to the following address:
|
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/38 |
Prior notification of a concentration
(Case COMP/M.4830 — CVC/Samsonite)
Candidate case for simplified procedure
(Text with EEA relevance)
(2007/C 174/10)
|
1. |
On 17 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking CVC Capital Partners Group Sarl (‘CVC’, Luxembourg) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Samsonite Corporation (‘Samsonite’, USA) by way of purchase of shares. |
|
2. |
The business activities of the undertakings concerned are:
|
|
3. |
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
|
4. |
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4830 — CVC/Samsonite, to the following address:
|
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/39 |
Prior notification of a concentration
(Case COMP/M.4744 — INEOS/Borealis)
(Text with EEA relevance)
(2007/C 174/11)
|
1. |
On 19 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking INEOS Group Limited (‘INEOS’, United Kingdom) belonging to the INEOS Group acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Borealis AS (‘Borealis’, Norway) belonging to the Borealis Group by way of purchase of shares. |
|
2. |
The business activities of the undertakings concerned are:
|
|
3. |
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
|
4. |
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4744 — INEOS/Borealis, to the following address:
|
|
27.7.2007 |
EN |
Official Journal of the European Union |
C 174/40 |
Prior notification of a concentration
(Case COMP/M.4734 — INEOS/Kerling)
(Text with EEA relevance)
(2007/C 174/12)
|
1. |
On 19 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking INEOS Group Limited (‘INEOS’, United Kingdom) belonging to the INEOS Group acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Kerling ASA (‘Kerling’, Norway) belonging to the Norsk Hydro Group by way of purchase of shares. |
|
2. |
The business activities of the undertakings concerned are:
|
|
3. |
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
|
4. |
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4734 — INEOS/Kerling, to the following address:
|